Evidence map›Paper›PMID 28760904›Full record

ArticleAntimicrobial agents and chemotherapy2017

Molecular Characterization of Fluoroquinolone-Resistant Moraxella catarrhalis Variants Generated

Kageto Yamada, Ryoichi Saito, Saori Muto, Machiko Kashiwa, Yoshiko Tamamori, Shingo Fujisaki

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kageto YamadaDepartment of Biomolecular Science, Faculty of Science, Toho University, Chiba, Japan kageto_yamada@tokyo-hmt.jp.
Ryoichi SaitoDepartment of Microbiology and Immunology, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Tokyo, Japan.ORCID 0000-0003-3398-8572
Saori MutoDepartment of Clinical Laboratory, Tokyo Metropolitan Health and Medical Treatment Corporation Toshima Hospital, Tokyo, Japan.
Machiko KashiwaDepartment of Clinical Laboratory, Tokyo Metropolitan Health and Medical Treatment Corporation Toshima Hospital, Tokyo, Japan.
Yoshiko TamamoriDepartment of Clinical Laboratory, Tokyo Metropolitan Health and Medical Treatment Corporation Toshima Hospital, Tokyo, Japan.
Shingo FujisakiDepartment of Biomolecular Science, Faculty of Science, Toho University, Chiba, Japan.
Toshima Hospital · JPToho University · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBase SequenceDNA GyraseDNA Topoisomerase IVLevofloxacinMicrobial Sensitivity TestsMoraxella catarrhalisMoraxellaceae InfectionsMutationRespiratory Tract InfectionsSelection, GeneticSequence Analysis, DNATopoisomerase InhibitorsAnti-Bacterial AgentsDNA GyraseDNA Topoisomerase IVLevofloxacinTopoisomerase InhibitorsfluoroquinolonegyrMoraxella catarrhalisparquinolone resistance-determining region

Identifiers

PMID28760904
PMCPMC5610493
OpenAlexW2739876859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.